Donating plasma is similar in many ways to
whole blood donation, though the end product is used for different purposes. Most plasmapheresis is for
fractionation into other products; other blood donations are transfused with relatively minor modifications. Plasma that is collected solely for further manufacturing is called Source Plasma. Plasma donors undergo a screening process to ensure both the donor's safety and the safety of the collected product. Factors monitored include
blood pressure,
pulse, temperature, total protein,
protein electrophoresis, health history screening similar to that for whole blood, as well as an annual physical exam with a licensed physician or an approved physician substitute under the supervision of the physician. Donors are screened at each donation for viral diseases that can be transmitted by blood, sometimes by multiple methods. For example, donations are tested for
HIV by
ELISA, which shows if they have been exposed to the disease, as well as by nucleic acid methods (
PCR or similar) to rule out recent infections that the ELISA test might miss and are also screened for
hepatitis B and
hepatitis C. Industry standards require at least two sets of negative test results before the collected plasma is used for injectable products. The plasma is also treated in processing multiple times to inactivate any virus that was undetected during the screening process. In a few countries, plasma (like blood) is donated by unpaid volunteers. In others, including the United States, Austria, Germany and some Canadian facilities plasma donors are paid for their donations. Standards for donating plasma are set by national regulatory agencies such as the
U.S. Food and Drug Administration (FDA), the
European Union, and by a professional organization, the Plasma Protein Therapeutics Association (or PPTA), which audits and accredits collection facilities. A
National Donor Deferral Registry (NDDR) is also maintained by the PPTA for use in keeping donors with prior positive
viral antibody test results from donating at any facility. Almost all plasmapheresis in the US is performed by automated methods. In some cases, automated plasmapheresis is used to collect plasma products like
fresh frozen plasma for direct transfusion purposes, often at the same time as
plateletpheresis. These procedures are performed at facilities such as
community blood centers. Since returning
red cells causes the body to replace plasma more rapidly, a donor can provide up to a liter of plasma at a time and can donate with only a few days between donations, unlike the 56-day deferral for blood donation. The amount allowed in a donation varies vastly from country to country, but generally does not exceed two donations, each as much as a liter (one-third of the total plasma volume), per seven-day period. If a significant amount of red blood cells cannot be returned, the donor may not donate for 56 days, just as if they had donated a unit of blood. Depending on the collection system and the operation, the removed plasma may be replaced by
saline. The body typically replaces the collected volume within 24 hours, and donors typically donate up to twice a week, though this varies by country. The collected plasma is promptly frozen at lower than -20 °C (-4 °F) and is typically shipped to a processing facility for fractionation. This process separates the collected plasma into specific components, such as
albumin and
immunoglobulins, most of which are made into medications for human use. Sometimes the plasma is thawed and transfused as Fresh Frozen Plasma (FFP), much like the plasma from a normal blood donation. ; Manual method : For the manual method, approximately the same as a
whole blood donation is collected from the donor. The collected blood is then separated by centrifuge machines in separate rooms, the plasma is pressed out of the collection set into a satellite container, and the red blood cells are returned to the donor. : The danger with this method was that if the wrong red blood cells were returned to the donor, a serious and potentially fatal
transfusion reaction could occur. Requiring donors to recite their names and ID numbers on returned bags of red cells minimized this risk. This procedure has largely become obsolete in favor of the automated method. ; Automated method machine being used for plasmapheresis : The automated method uses a very similar process. The difference is that the collection, separation, and return are all performed inside a machine connected to the donor through a needle in the arm, typically the
antecubital vein. There is no risk of receiving the wrong red cells. The devices used are very similar to the devices used for therapeutic plasmapheresis, and the potential for citrate toxicity is similar. The potential risks are explained to prospective donors at the first donation, and most donors tolerate the procedure well. In the UK in 2020, plasma donation is sought from volunteers who have recovered from
COVID-19. ; Antibodies : Donors are sometimes immunized against agents such as
tetanus or
hepatitis B so that their plasma contains the antibodies against the toxin or disease. In other donors, an intentionally incompatible unit of blood is transfused to produce antibodies to the antigens on the red cells. The collected plasma then contains these components, which are used in manufacturing of medications. Donors who are already ill may have their plasma collected for use as a positive control for laboratory testing. == History ==